EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
The EAHP EU Monitor is a weekly round up of news relevant to hospital pharmacy in Europe.
You can subscribe to the EAHP EU Monitor here.
The European Association of Hospital Pharmacists (EAHP) has published headline results of a recent survey that reveals 99% of responding hospital pharmacists say they have experienced difficulties with medicines shortages in the past year.
With over 300 respondents from 27 countries, the survey also uncovered that 63% of hospital pharmacists report medicines shortages to be a weekly, sometimes daily occurrence, and that 77% consider that problem has become worse in the last year.
Announcing the results at a reception in the European Parliament on access to medicines, EAHP President Dr Roberto Frontini said:
“These headline results confirm what I have increasingly heard from our member across Europe: that the shortages problem is widespread, doesn’t respect national borders, and urgently requires attention if patient care and health services are not to suffer.
Managing shortages and trying to source supply distracts pharmacists from other core tasks, places burden on support staff and can increase stress and workload in the pharmacy environment with consequent impacts on the risk of error. Substitution of medicines in case of shortage of formulary drugs can also confuse doctors and nurses, further raising risks to patient safety.
I want to take this opportunity at the European Parliament to call on all partners to work together in identifying and enacting solutions. This includes industry and supply chain actors, regulatory authorities, and all health professions involved in medicines. I also believe there is a role for the European Commission in bringing Governments and others together on this issue.”
EAHP will present the full results of its survey at its forthcoming Congress in Paris, 13-15th March, 2013.
More information here.
The EMA has issued a range of opinions on new medicines seeking market approval and published a consultation on two standard paediatric investigation plans (PIPs) for two specific types of cancer with unmet medical needs in children.
Sanofi Pasteur received a positive opinion from the EMA Committee for Medicinal Products for Human Use (CHMP) recommending market approval for a new 6-in-1 pediatric vaccine Hexyon/Hexacima (DTaP-IPV-Hib-HepB vaccine).
The CHMP also backed French firm Lucane Pharma's Pheburane (sodium phenylbutyrate) for the treatment of chronic management of urea-cycle disorders and expanded use of GlaxoSmithKline's human papillomavirus vaccine Cervarix and CSL Behring's intravenous immunoglobulin therapy Privigen. The EMA also issued positive recommendations for generics of Lundbeck's Alzheimer's disease drug Ebixa (memantine) from Mylan and Actavis.
More information here:
Separately, the Agency has opened a public consultation on two standard paediatric investigation plans (PIPs) for two specific types of cancer with unmet medical needs in children, acute myeloid leukaemia and rhabdomyosarcoma.
A PIP sets out a programme for the development of a medicine to ultimately authorise its use in children.
Comments on these documents should be submitted by 5 May 2013.
More information here:
EJHP April 2013, Volume 20, Issue 2 is now online with the special theme of ‘Safety and hospital pharmacy’.
The edition includes:
Full edition here:
With just two weeks until the 18th congress of the EAHP, Nicolas Janus previews the special Thursday afternoon session on highlights of French Hospital Pharmacy..
Hosted and led by EAHP’s Member Association for France, the Européenne de Formation pour les Pharmaciens (EFP), the session will share 3 noteworthy aspects of current hospital pharmacy practice in France:
1. Medication reconciliation and electronic pharmaceutical files of patients;
2. Integrated chemotherapy services: from hospital compounding to home-based administration to the patient; and,
3. 14 years of experience of a nation-wide information centre on drug and kidney
Preview of session here.
Session abstract here.
This year’s Congress has the overall theme “Improving patient outcomes: a shared responsibility”
Registration information here.
Information on the Scientific Programme here.
